Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pascoe

Showing results (191-200 of 223) with videos related to

Pageof 23
Sort By:
Canadian Journal of Kidney Health and Disease|August 19, 2015
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialSunil V Badve, Lei Zhang, Jeff S Coombes, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 2, 2006
Overview of a paediatric renal transplant programmeM I McCulloch, P Gajjar, C W N Spearman, et al.
Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 16, 2011
Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsL Fenner, M Forster, A Boulle, et al.
Plos One|March 25, 2021
Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysisJuan Pei, Yeoungjee Cho, Yong Pey See, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
The Medical Journal of Australia|May 4, 2025
Incidental findings during lung low-dose computed tomography cancer screening in Australia and Canada, 2016-21: a prospective observational studyAsha Bonney, Diane M Pascoe, Mark W McCusker, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2017
Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic ReviewAndrea K Viecelli, Emma O'Lone, Benedicte Sautenet, et al.
Pageof 23

Showing results (191-200 of 223) with videos related to

Sort By:
Pageof 23
Canadian Journal of Kidney Health and Disease|August 19, 2015
Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialSunil V Badve, Lei Zhang, Jeff S Coombes, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|November 2, 2006
Overview of a paediatric renal transplant programmeM I McCulloch, P Gajjar, C W N Spearman, et al.
Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|July 16, 2011
Tuberculosis in HIV programmes in lower-income countries: practices and risk factorsL Fenner, M Forster, A Boulle, et al.
Plos One|March 25, 2021
Impact of deceased donor with acute kidney injury on subsequent kidney transplant outcomes-an ANZDATA registry analysisJuan Pei, Yeoungjee Cho, Yong Pey See, et al.
Nephrology (Carlton, Vic.)|May 13, 2016
Association between serum hepcidin-25 and primary resistance to erythropoiesis-stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialJoel Gummer, Robert Trengove, Elaine M Pascoe, et al.
Trials|May 27, 2020
Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantationMichael G Collins, Magid A Fahim, Elaine M Pascoe, et al.
The Medical Journal of Australia|May 4, 2025
Incidental findings during lung low-dose computed tomography cancer screening in Australia and Canada, 2016-21: a prospective observational studyAsha Bonney, Diane M Pascoe, Mark W McCusker, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 6, 2017
Vascular Access Outcomes Reported in Maintenance Hemodialysis Trials: A Systematic ReviewAndrea K Viecelli, Emma O'Lone, Benedicte Sautenet, et al.
Pageof 23